Examkin

Question

Difficulty: HardPharmacologic Interventions

A 62-year-old man is evaluated in the intensive care unit for new-onset fever, increased purulent endotracheal secretions, and worsening oxygenation. He was intubated 6 days ago for severe blunt chest trauma following a motor vehicle collision. His medical history is significant for a severe, IgE-mediated anaphylactic allergy to penicillin, documented as causing diffuse urticaria, angioedema, and respiratory failure. Vital signs show a temperature of 39.2°C (102.6°F), heart rate of 122/min, and blood pressure of 82/45 mmHg despite the administration of 3 liters of intravenous crystalloid. He is started on a norepinephrine infusion. A chest radiograph reveals a new dense infiltrate in the right lower lobe. The patient requires prompt initiation of empiric antimicrobial therapy for suspected ventilator-associated pneumonia and septic shock. Which of the following antimicrobial agents should be included in this patient's empiric regimen? (Select all that apply)

  1. Intravenous aztreonamAnswer
  2. Intravenous ciprofloxacinAnswer
  3. C
    Intravenous daptomycin
  4. Intravenous linezolidAnswer
  5. E
    Intravenous meropenem

Answer

The appropriate empiric regimen for this patient includes intravenous aztreonam, intravenous ciprofloxacin, and intravenous linezolid.
The correct regimen for this patient includes intravenous aztreonam, ciprofloxacin, and linezolid. This patient has ventilator-associated pneumonia (VAP) complicated by septic shock. According to IDSA/ATS guidelines, patients with VAP and septic shock require empiric coverage for methicillin-resistant Staphylococcus aureus (MRSA) and two antipseudomonal agents from different classes to ensure adequate initial coverage and reduce mortality. Linezolid provides excellent MRSA coverage and strong lung penetration. For the required double antipseudomonal coverage in a patient with a severe, life-threatening IgE-mediated penicillin allergy, a monobactam like aztreonam is the agent of choice because it does not cross-react with other beta-lactams. A fluoroquinolone like ciprofloxacin is appropriate as the second antipseudomonal agent from a different class.

Step-by-Step Solution

1
Identify the clinical condition and severity.
The patient has ventilator-associated pneumonia (VAP) complicated by septic shock.
Establishing illness severity determines the breadth of empiric antimicrobial coverage required.
2
Determine the required antimicrobial spectrum according to guidelines.
The patient requires coverage for MRSA and double antipseudomonal coverage from different antibiotic classes.
IDSA/ATS guidelines recommend this broad three-drug approach for VAP patients presenting with septic shock due to the high risk of mortality and resistant organisms.
3
Select appropriate agents considering the patient's severe penicillin allergy.
Select linezolid for MRSA, aztreonam as the first antipseudomonal agent, and ciprofloxacin as the second antipseudomonal agent.
Aztreonam is the only safe cell-wall active antipseudomonal agent in severe penicillin anaphylaxis. Daptomycin cannot be used for pneumonia, and meropenem poses an allergy cross-reactivity risk.

Key Concept

Empiric treatment of ventilator-associated pneumonia (VAP) in patients with septic shock requires MRSA coverage and double antipseudomonal coverage; aztreonam is the beta-lactam of choice in severe penicillin allergy, and daptomycin is absolutely contraindicated for lung infections.
Rate this question

Topics

Pharmacologic Interventions

More questions from this topic